[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/biz/ - Business & Finance


View post   

File: 30 KB, 373x223, 95c55c5d6881aee8530f0f7a44db7db2.jpg [View same] [iqdb] [saucenao] [google]
24915853 No.24915853 [Reply] [Original]

What psychedelic stocks would you recommend?

CYBIN (Cybin)

psilocybin targets major depressive disorder
phase 2 trial, looks legit
solid team
IPOd in September at 0.69USD, currently 1.88USD
latest news: Cybin Closes Acquisition Of Adelia Therapeutics; Bolsters Scientific Team And Grows IP Portfolio To 7 Patent Filings

NUMI (Numinus Wellness)

ketamine-assisted psychotherapy
special access & compassionate access for psilocybin & MDMA pending approval in Vancouver and Montreal
no idea about the team
IPOd in May at 0.87CAD, currently 1.86CAD

MYCOF (Mydecine Innovations Group)

clinical trials focusing on Veterans, EMS, and First Responders with a PTSD indication
own Mindleap Health, Mydecine Health Sciences, and Neuropharm Inc.
don't know anything about the team
IPOd in 2015 at 7.70, currently at 0.41

RVVTF (Revive Therapeutics)

in psychedelics partnered with University of Wisconsin-Madison
cannabis and covid, phase 3 for covid treatment
acquired Psilocin Pharma Corp.
IPO'd at 0.41, currently at 0.56

CMPS (Compass Pathways)

Blue Chip of the psychedelics
targeting Treatment-resistant depression
received FDA Breakthrough Therapy designation for our programme of psilocybin therapy in treatment-resistant depression in 2018
IPOd at 8.50, currently at 57
Funded by Peter Thiel
has losses still, yet it has $196.5 million in cash, which it says will be enough to last it into 2023

>> No.24915865

absolutely none of them

>> No.24915886

CYBIN looks okay, considering buying the company desu

>> No.24917058

MMED/SHRM